Telephone: 01443 443999 Email: [email protected] Egg Sharing Information for Egg Providers What is Egg Sharing?
Egg sharing involves one woman (the egg provider) undergoing a cycle of IVF
treatment and providing some of her eggs to another woman (the recipient).
This increases the availability of eggs to potential recipients and enables the
egg provider to receive her own IVF treatment at a reduced cost. The Egg Provider Who can be an egg provider?
To be eligible to be an egg provider you should;
If you have polycystic ovaries you should be taking a drug cal ed
Have hormone levels within normal limits i.e. AMH more than 12.
Not have any transmittable diseases( infectious or inheritable)
Have no family history of inheritable disorders/ congenital
Have no history of poor ovarian response to stimulation.
Have no history of recurrent miscarriage ( 2 or more confirmed
Have less than 3 previous failed IVF attempts
Have no previous failed fertilisation
Have less than 3 previous attempts at egg sharing
Have had a previous IVF cycle which produced at least 8 good quality
eggs or a previous normal live birth.
PI Egg Sharing- Provider V1 AOL July 2010
How do I join the egg share programme as a provider?
You can contact us at CRGW on 01443 443 999. We may need to
approach your GP regarding your suitability to be a donor.
You wil be invited for a consultation. At this visit we wil take a medical,
fertility and family history from you/partner. We wil need to exclude the
possibility of inheritable disorders including Prion disease
You wil need a physical examination as part of your general health
We wil plan your investigations/screening tests and discuss how we
assess your suitability as an egg provider. Screening
This is to prevent transmission of infection or increased risk of abnormalities
in any children born from treatment.
Blood group and rhesus antigen status
Genetic tests for chromosomal abnormalities including the test for the
Specific tests related to ethnicity wil also be carried out; Thalassaemia
(Eastern Mediterranean), Sickle Cel (Afro-Caribbean ),Tay-Sacs
Vaginal swabs for general infection, Chlamydia and gonorrhoea
HIV and Hepatitis Band C (blood tests) 2 tests taken 3 months apart
N.B. HIV and Hepatitis B and C are carried out before being accepted onto
the programme and are repeated at the start of any treatment cycle. This
does not completely exclude the possibility of these viruses, as due to the
nature of the test false positive and false negative results can occur.
PI Egg Sharing- Provider V1 AOL July 2010
Screening may reveal an unsuspected infectious or genetic condition which
may have implications for your future health or the health of your family. We
wil , of course, do appropriate tests and provide counsel ing. Welfare of the child
As with al fertility treatments the Human Fertilisation and Embryology
Authority (HFEA) code of practice requires that we assess the suitability of
you/your partner to be parents. This is done by you completing a
questionnaire. If there are any issues raised from this we may need to contact
your GP or other relevant professional. We wil ask you to complete 'Consent
to Disclosure' before we make these enquiries. It may also be necessary to
discuss this at our social and ethical issues group. Counselling
Prior to acceptance onto the programme we wil ask you/partner to be seen by
an independent counsel or who wil explore ethical and legal issues with you.
The counsel or may also discuss any welfare of the child issues that have
arisen or, if appropriate, any feedback from our clinic meeting group. Ethical Issues
These are some of the issues which you should consider;
How wil you feel about someone else having a child conceived from
How wil you feel if the recipient is successful, but the treatment does
Consider what anonymous information you would like to receive about
the recipient’s treatment, bearing in mind that donor anonymity has
been removed and there is the potential that a child may make contact
How wil you feel if a child born from treatment contacts you when they
are 18 years old? The law now al ows access to identifying information
when they are 18. We encourage parents of donor conceived children
to tel the child from an early age how they were conceived as it is
important for them to know about their origins. We encourage them to
seek advice about how to do this from the Donor Conception website.
You should consider the needs of any existing children or children born
There is also a possibility that children born as a result of treatment
could be unknowing siblings and may live in the same geographical
PI Egg Sharing- Provider V1 AOL July 2010
Legal Issues
Since 1991 the HFEA has kept a confidential register of information about al
sperm, egg and embryo donations. This includes for al donors a physical
description, ethnicity and (if provided) occupation and interests. The register
includes al treatments and resulting children. The fol owing information can
Information donor – conceived individuals can receive 18 year olds will be able to obtain
Identifying information about the donor including name, address, date
of birth and physical appearance if the donation was made after April
Identifying information on donations made prior to April 2005 if the
donor has retrospectively removed anonymity
Anonymous information if the donation was made before April 2005
Those who intend to marry or enter into a civil partnership can submit a
joint application to establish whether they are genetical y related.
Non-identifying information about their donor- conceived genetical y
related siblings including number, sex and year of birth.
18 year olds wil be able to find out identifying information about donor-
conceived genetical y related siblings, if both sides consent, and wil be
able to find out about their donor, if applicable
16 year olds will be entitled to
Non identifying information about their donor and their donor -
conceived genetical y related siblings.
16 year olds who intend to enter an intimate physical relationship can
find out whether they are genetical y related. Information parents of donor-conceived individuals can receive
They can be provided with non-identifying information about the donor
by the clinic when they receive treatment
Upon request the HFEA can provide them with the number, sex and
year of birth of other offspring of the same donor
Information donors can receive
They have the right to access the fol owing anonymous information
about their genetic offspring; number, sex and year of birth of people
The HFEA is expected to contact and forewarn a donor of the fact that
a donor conceived individual has requested identifying information
Donors wil be able to contact the clinic or the HFEA for this
PI Egg Sharing- Provider V1 AOL July 2010
Further Legal Issues
The egg provider may withdraw her consent to the agreement at any
time before any eggs or embryos created from the treatment are
transferred into the recipient, used for research or al owed to perish
The outcomes of the treatment cycles may be disclosed to the provider
and recipient if both have consented ( This is up to the individual and
We can give the recipient non-identifying information about the provider
and we also encourage the provider to write a short biography which
can be given to any child resulting from treatment
Egg providers have no legal claim to any children born from their
It is il egal for payment to be made as part of an egg share
Medical Issues
You may not produce enough fol icles or eggs to continue the egg
sharing arrangement. This cannot be anticipated as ovarian response
to stimulation can vary in different treatment cycles and may happen
even if you have previously had a good response.
As with al IVF cycles there is a risk of over response which can have
serious complications. Although we would like you to produce enough
eggs to share we aim to avoid ovarian hyper-stimulation and would
Because you are sharing your eggs there may not be any/many
embryos to freeze. You should also be aware that frozen embryo
cycles are less successful than fresh embryo cycles.
In an egg sharing arrangement both you and the recipient have fertility
problems. You may have an undetected egg problem which wil affect
your treatment and that of the recipient.
We would emphasise that neither you nor the egg recipient should feel
under pressure to go ahead with the treatment.
It is essential for the wel being of any children born as a result of the
treatment that you disclose al of your personal and family medical
history. If a child is born with a disability due to you withholding
information regarding conditions about which you knew, or could be
reasonably expected to know, then he/she may sue you personal y for
In the future if you discover a previously unsuspected genetic
condition, the clinic and the HFEA should be immediately informed.
Consideration would be given to informing recipients who have had live
births or where pregnancy is ongoing. In these circumstances
appropriate tests would be arranged and counsel ing offered.
PI Egg Sharing- Provider V1 AOL July 2010
The Treatment Cycle
The treatment involves you undergoing a cycle of IVF at the same time the
recipient takes medication to prepare her womb for embryo transfer.
To al ow synchronisation of your cycles you both need to commence either
the oral contraceptive pil (if not contraindicated) or a progesterone tablet. We
wil fol ow this with daily injections of a drug cal ed Suprecur. This is designed
to “switch off” your hormones to al ow us to manipulate your cycle. After 2-3
weeks on these injections their effect is checked by a baseline scan. When
your hormones are “switched off” you then start a second daily injection to
stimulate the ovaries. You wil continue both injections for approximately 2
weeks, with regular scans to monitor your progress. For a full description of an IVF cycle please see our information leaflet on IVF/ICSI treatment.
Fol owing egg col ection you wil be asked to share 50% of your eggs with the
recipient. Your eggs wil be inseminated with your partners/donor sperm. The
recipient’s share of the eggs wil be inseminated with her partner’s
We wil ask you to use pessaries/injections to encourage pregnancy to occur
and to do a pregnancy test 16 days after embryo transfer. As with al fertility
treatments there is a risk of ectopic and multiple pregnancies.
No more than 2 embryos can be transferred into your womb. To reduce the
risks of a multiple pregnancy we now encourage a single embryo transfer. Consents
There are number of consents and forms for you/partner to complete before
We wil require a copy of your passport (which can be taken at the
You wil need to consent if we are to keep your GP informed of your
progress or if we need to request information from them in the event of
Consent to use and storage of eggs and embryos (female)
Consent to treatment and embryo transfer (female)
Consent to use of eggs in donation (female)
Consent to use and storage of sperm and embryos (male)
If using donor sperm there wil be additional consents concerning legal
parenthood (see information sheet regarding the use of donor sperm)
The egg sharing agreement.(al concerned)
PI Egg Sharing- Provider V1 AOL July 2010
The Egg Sharing Agreement N.B. There is a separate consent form for the agreement and the fol owing
If you produce 6 or more eggs you wil share 50% with the recipient.
I you produce an odd number you wil get the extra egg.
If you get less than 6 eggs we believe there are too few to share and
you may keep al your eggs (at no additional cost). However we would
consider your response as unsuitable to take part in any further egg
If you have less than 6 fol icles on day 10 of the stimulation you may
continue to egg col ection and keep al eggs for your own use( at no
additional cost), unless you both agree to continue with the agreement.
We would consider your response as unsuitable for further egg
If you withdraw from an egg sharing agreement during your ovarian
stimulation without a clinical reason you can choose to cease
treatment , donate al your eggs as an altruistic donor or keep al the
If the recipient withdraws from the agreement during stimulation and
an alternative cannot be found you may continue to egg col ection and
keep al the eggs with no additional cost.
The cost of the treatment and the drugs is born by recipient
If additional procedures are required the individual requiring them wil
meet the costs. Additional procedures include; ICSI, Donor Sperm,
Embryo freezing (after the first year), Sperm freezing and Assisted
Divulging Information
Neither you nor the egg recipient wil have identifying information about the
other and we wil ensure that you attend clinic on different days or times, and
are treated by different members of staff.
You can both consent if you wish to having/divulging information about the
outcomes of each other’s cycles. You may not wish to do this and we respect
N.B. Please note the information donors, donor-conceived individuals and
parents of donor-conceived individuals can now obtain. (See under legal
PI Egg Sharing- Provider V1 AOL July 2010
Southeastern Pain Consultants, P.C. 770 982-2099 Pre Procedure Instructions Take all of your prescription medications as prescribed on the day of your procedure EXCEPT those noted below: Stop all anti-platelet drugs one week prior to your procedure and restart them after the procedure. Examples of drugs in this class include: anagrelide (Agrylin), clopidogrel (Plavix), dipyridamo
CAULKING AND WEATHERIZATION Autumn may be a confusing time of year if you need to seal up your house for the coming winter. Where do you use caulking? Weatherstripping? Glazing? How are they different? Don't feel alone in your confusion. There are a lot of products available, and the differences among them, where you use them, and how you use them would likely confuse many home buil